Table 1.
Baseline characteristics of participants
| eTAU (n = 43) | WHO CST (n = 43) | |||||
|---|---|---|---|---|---|---|
| N | n (%) | M (SD) | n (%) | M (SD) | p | |
| Child | ||||||
| Male | 86 | 34 (79.1) | 33 (76.7) | .500 | ||
| Age in months | 86 | 44.21 (9.01) | 45.56 (10.06) | .514 | ||
| Time since diagnosis | 81 | 13.86 (10.48) | 14.38 (9.96) | .603 | ||
| Cognitive ability (Griffiths III GD AE) | 86 | 22.84 (6.98) | 23.84 (6.93) | .507 | ||
| Autism severity (ADOS-2) | 85 | |||||
| Total CSS | 7.00 (2.00) | 6.83 (2.34) | .725 | |||
| SA CSS | 6.93 (2.18) | 6.95 (2.18) | .963 | |||
| RRB CSS | 8.47 (1.55) | 7.95 (2.06) | .197 | |||
| Level of language (ADOS-2 Item A1) | 86 | |||||
| Non-verbal | 13 (30.2) | 13 (30.2) | .839 | |||
| Single words | 24 (55.8) | 21 (48.8) | ||||
| Two-word utterances | 3 (6.9) | 4 (9.3) | ||||
| Phrase speech | 3 (6.9) | 5 (11.6) | ||||
| Current use of medication | 86 | |||||
| Sleep medication | 5 (11.6) | 10 (23.3) | .155 | |||
| Antiepileptic medication | 1 (2.3) | 1 (2.3) | 1.0 | |||
| Primary caregiver | ||||||
| Mother | 86 | 37 (88.1) | 30 (69.7) | .069 | ||
| Age | 84 | 36.6 (5.51) | 36.88 (5.6) | .815 | ||
| Non-Italian nationality | 86 | 12 (27.9) | 14 (32.6) | .621 | ||
| Educational level | 84 | |||||
| Elementary/middle school | 11 (26.2) | 9 (21.4) | .687 | |||
| High school diploma | 24 (57.1) | 23 (54.8) | ||||
| Degree and post-degree | 7 (16.7) | 10 (23.8) | ||||
Griffiths III GD AE Griffiths III General Development age equivalents, ADOS-2 Total CSS, SA CSS, RRB CSS Autism Diagnostic Observation Schedule Second Edition Composite Severity Scores for Total, Social Affect and Restricted and Repetitive Behaviors, ADOS-2 Item A1 Autism Diagnostic Observation Schedule Second Edition, Item A1 'Overall level of non-echoed spoken language', across modules